Joysbio Spucktest SARS-CoV-2 Antigen rapid test kit - Profitest - Medical Deal
Joysbio Spucktest SARS-CoV-2 Antigen rapid test kit - Profitest - Medical Deal
Joysbio Spucktest SARS-CoV-2 Antigen rapid test kit - Profitest - Medical Deal
Joysbio Spucktest SARS-CoV-2 Antigen rapid test kit - Profitest - Medical Deal
Joysbio

Joysbio spit test SARS-CoV-2 antigen rapid test kit - professional test

SKU: JBPT1000
(0)
28,90 € inkl. MwSt.
Out of stock
Leider nicht vorrätig
Versandkostenfrei ab 200 €*
Persönlicher Kundenservice
Für Gewerbe & Privatkunden
Zahlungsarten
  • American Express
  • Apple Pay
  • Google Pay
  • Klarna
  • Maestro
  • Mastercard
  • PayPal
  • Shop Pay
  • Union Pay
  • Visa

Dies ist nur eine Auswahl - für B2B Kunden bieten wir auch Rechnungskauf an. Kontaktieren Sie uns gerne.

Sie sind Großabnehmer?

Für größere Mengen oder Rahmenverträge erstellen wir Ihnen ein individuelles Angebot mit passenden Konditionen. Angebot anfragen

Noch Fragen?

Video chat Chat Email 04052477340

With the new JOYSBIO-SARS COV-2 antigen saliva test No more penetration of the nose or throat is necessary. The biggest advantage of a saliva test over a swab test is its very simple and quick application.

  • For the qualitative detection of an acute SARS-CoV-2 infection (Corona / Covid-19)
  • Test result available after just 15 minutes
  • Saliva sample sufficient for the spit test
For the qualitative in vitro detection of SARS-CoV-2 nucleocapsid antigen in oral fluid directly from individuals suspected of having COVID-19. COVID-19 viral antigen is detectable in oral fluid samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The detected pathogen may not be the definitive cause of disease.

Swab methods :

Saliva is sufficient – ​​no nasal swab required

Details at a glance:

  • Recognition of test results throughout the European Union
  • Specificity: 99.55% (97.50%～100.00%)
  • Sensitivity: 98.18% (93.60%～99.80%)
  • evaluated by the Paul Ehrlich Institute
  • BfArM label: AT 527/20
  • Limit of detection (LoD ): 
  • Detection of the following virus variants: Omicron, Delta & Epsilon

For further information please refer to the data sheets.